Glaucoma Surgery Devices Market Size

The Global Glaucoma Surgery Devices Market, valued at US$ 1.1 billion in 2022, is set for significant expansion, projected to reach US$ 6.0 billion by 2031. With an impressive CAGR of 24.2% anticipated during the forecast period from 2024 to 2031, the market is poised for lucrative growth.

The Glaucoma Surgical Devices Market focuses on reducing intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. These devices aim to lower IOP, preventing further damage to the optic nerve and halting the progression of the disease. The main goal of glaucoma therapy within the Glaucoma Surgical Devices Market is to effectively reduce IOP.


The Glaucoma Surgical Devices Market size is expanding rapidly due to several key factors. The increasing prevalence of glaucoma and the rising global geriatric population, which is more susceptible to eye diseases, are major contributors. Additionally, there is a growing demand for minimally invasive glaucoma surgery (MIGS) procedures, and continuous technological advancements in glaucoma surgery devices are further driving the growth of the Glaucoma Surgical Devices Market size.

For More Insights request free sample:

https://www.datamintelligence.com/download-sample/glaucoma-surgery-devices-market


Glaucoma Surgery Devices Market Dynamics

Significant advancements in glaucoma surgery have been driven by innovative surgical techniques, devices, and technologies. Notably, laser technology is playing a growing role in this field. Laser trabeculoplasty, or selective laser trabeculoplasty (SLT), utilizes laser energy to enhance fluid outflow from the eye, effectively reducing intraocular pressure. These advancements in glaucoma surgery techniques and technologies are transforming patient outcomes in the Glaucoma Surgical Devices Market.

Endoscopic cyclophotocoagulation (ECP) is a laser-assisted treatment that uses laser energy to reduce the production of aqueous humor in the eye. In February 2023, Belkin Vision announced the use of their Direct SLT Eagle device, a non-contact, automated glaucoma laser therapy, for treating glaucoma patients. These innovations highlight the continuous advancements in laser treatments within the Glaucoma Surgical Devices Market, enhancing patient care and outcomes.


Rise in the Incidence of Ocular Disorders

The growing prevalence of eye diseases is a significant driver fueling market growth in the Glaucoma Surgical Devices Market during the forecast period. For example, according to the WHO, approximately 2.2 billion people worldwide have near or far vision impairments. It's estimated that in nearly half of these cases, vision impairment could have been prevented or treated. This underscores the critical role of advancements in Glaucoma Surgical Devices Market in addressing global eye health challenges.

This figure of 1 billion includes individuals affected by moderate to severe distance vision impairment or blindness caused by uncorrected refractive error (88.4 million), cataracts (94 million), age-related macular degeneration (8 million), glaucoma (7.7 million), diabetic retinopathy (3.9 million), and near vision impairment due to uncorrected presbyopia (826 million). These statistics highlight the diverse range of eye conditions contributing to the global burden addressed by innovations in the Glaucoma Surgical Devices Market.


Expense of Surgical Procedures

The high cost associated with glaucoma surgery poses a significant restraint on market growth during the forecast period. For example, while laser surgery, considered more affordable, typically costs between $1,000 to $2,000, incisional surgery can be considerably more expensive, averaging around $11,000. This cost barrier highlights a challenge for broader adoption of surgical treatments within the glaucoma market.


For customized report:

https://www.datamintelligence.com/customize/glaucoma-surgery-devices-market

Glaucoma Surgery Devices Market Segmentation:

Global glaucoma surgery devices are categorized by product type, surgery type, end-user, and region.

Minimally Invasive Glaucoma Surgery (MIGS) accounted for approximately 42.7% of the market share in Glaucoma Surgery Devices.


The segment of minimally invasive glaucoma surgery, commanding approximately 42.7% of the Glaucoma Surgery Devices market size, is poised for dominance throughout the forecast period. Minimally invasive glaucoma surgery (MIGS) aims to reduce or prevent optic nerve damage by lowering intraocular pressure.

In recent years, MIGS procedures have increasingly replaced traditional glaucoma surgeries, aiming to mitigate the challenges associated with conventional methods. While traditional approaches like external tube shunts and trabeculectomy effectively reduce intraocular pressure and slow glaucoma progression, they also entail higher risks.

Glaucoma Surgery Devices market

By Product Type:
Punches
USC Marker
USC Planer
USC Shaver
Probes & Alger brushes
Glaucoma Drainage Devices

By Surgery Type:
Trabeculectomy
Tube Shunt Implantation
Cyclophotocoagulation
MIGS

By End Users:
Ophthalmic Clinics
Diagnostic Centers


View Full Report: 

https://www.datamintelligence.com/enquiry/glaucoma-surgery-devices-market


Glaucoma Surgery Devices Market Regional:

In 2022, North America held about 39.1% of the market share.

Throughout the forecast period, North America is projected to maintain approximately 39.1% of the total market share in the Glaucoma Surgery Devices market size. This dominance is expected due to the concentration of key market players in the region, leveraging strategies such as product launches, regulatory approvals, acquisitions, and expansions to capture a significant portion of the global market.

Glaucoma Surgery Devices market key players: 

key players are Ziemer Ophthalmic Systems AG, Corza Medical, Alcon, Inami & Co Ltd, Katalyst Surgical, Lumenis, Millennium Surgical, Moria Surgical, Zabbys, and Allergan among others

Related Reports

Europe-medical-simulation-market

https://www.datamintelligence.com/research-report/europe-medical-simulation-market


Minimally-invasive-glaucoma-surgery-devices-market

https://www.datamintelligence.com/research-report/minimally-invasive-glaucoma-surgery-devices-market


About Us:

Company Name: DataM Intelligence

Contact Person: Sai.K

Email: [email protected]

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com/


DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.